Precision Clinical Decision Support for Basal-Bolus Subcutaneous Insulin
Hospitals have long relied on sliding scale protocols to manage glycemic control in hospitalized patients who do not require intensive care, but expert recommendations and guidelines urge that hospitals adopt a safer, more effective approach: physiologic subcutaneous insulin protocols.
By making the shift away from sliding scale protocols to the recommended basal-bolus subcutaneous insulin therapy, providers have demonstrated:
- significantly fewer hyperglycemic and hypoglycemic episodes
- increased time in target glucose levels
- reduced length of stay8
ENDOTOOL SUBQ IS PRECISION INSULIN DOSING SOFTWARE
Supporting Industry Guidelines and Standards
EndoTool SubQ offers a streamlined solution to aid providers with physiologic insulin therapy, using basal, bolus and correction insulin for improved patient outcomes.
A Personalized Insulin Therapy Regimen to Manage Blood Glucose with Less Variability
Using a non-linear dosing model and machine-learning approach, EndoTool SubQ translates past data points into an individual physiological model for each patient.
Patient-Specific Dosing
EndoTool SubQ uses proprietary technology that models, predicts and adapts to each patient’s unique physiology and individual response to insulin. EndoTool SubQ provides insulin dose recommendations for adult and pediatric patients (as young as two years of age weighing at least 12 kg). The initial dose recommendation is based on 12 patient-specific factors, including diabetes diagnosis, kidney function, nutrition plan and presence of steroids.
Straightforward Start for Every Patient Situation
Initiating subcutaneous insulin therapy is straightforward and seamless with EndoTool SubQ. The software can determine the appropriate model from an IV protocol, a different SubQ protocol, or can calculate based on the patient information, protocol and expected carbohydrate intake.
Bolus Dosing
EndoTool SubQ dose recommendations are specific to each patient’s carbohydrate intake and blood glucose response. The Medical Director of each unit may determine the method used to count carbohydrates for patients eating meals, including number of grams, percentage of meal, or carbohydrate servings. Alternatively, for patients receiving tube feeding, total parenteral nutrition and/or IV dextrose, the software calculates and tracks the carbohydrate intake.
Limited Dosing Modes
For patients who have been assessed and require a limited insulin dosing regimen to meet their needs, modes for bolus plus correction and correction only are available, if enabled by the Medical Director.
The Tools and Support Needed to Make the Transition
The transition to basal-bolus subcutaneous insulin therapy can be challenging, requiring a hospital to address changes to workflow, educational deficits and clinical inertia. Monarch provides tools and support to help streamline this transition.
A Team Beside You Every Step of the Way
From the very beginning, the Monarch Professional Services Team helps you identify workflow challenges, provides education, and supports your adoption of EndoTool SubQ. Following implementation, your team continues to be supported 24/7/365 by EndoTool IT and clinical experts.
Conforming to Your Hospital’s Standards and Practices
EndoTool SubQ is flexible and customizable, with parameters that can be modified at the unit level to support preferred workflows, policies and protocols. The system is also capable of integration with your electronic medical record (EMR) system.
Data to Drive Adherence
With the ability to identify and analyze trends across the organization, the EndoTool Analytics application enables administrators and clinicians to track performance and enhance productivity.
ENDOTOOL SUBQ DATA SHEET
Check out the unique capabilities and benefits of EndoTool SubQ!
Download Now